Lipids in Health and Disease

Lipids in Health and Disease is published by BioMed Central and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health and Fatty Acid Research and Health, together about 36.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Lipids in Health and Disease is an open access, peer-reviewed journal that publishes articles on all aspects of lipids, such as their interaction with proteins and their pharmacological, (bio)chemical, and molecular effects at the organismal level. We are also interested in molecular toxicological investigations related to lipids and natural products that can interact with various aspects of lipids in health and disease. The synthesis and actions of new lipid compounds and enzyme systems involved in lipid synthesis and metabolism are of interest. Lipids in Health and Disease invites submissions from all scientists, health care professionals, and physicians in all areas of lipids. Lipids are defined herein in their broadest sense and include: cholesterol triacylglycerols fatty acids phospholipids sphingolipids glycosphingolipids remnant cholesterol inositol lipids sterols and oxysterols second messenger lipids (such as diacylglycerol and ceramide) storage and bioactive lipid forms lipid mediators (e.g., eicosanoids, resolvins) lipid‒protein conjugates structural lipids relevant to membranes and signaling pathways The journal publishes research that investigates and defines the role of lipids in various physiological and pathological processes including, but not limited to: enzymes and synthetic machinery involved in the metabolism of lipids in cells and tissues lipid transport energy storage and metabolism structural components of cell membranes hormone synthesis cellular signaling brain and nervous system function nutrient absorption and transport thermoregulation and protection cardiovascular diseases obesity and metabolic syndrome diabetes mellitus neurodegenerative diseases inflammatory and autoimmune diseases cancer liver diseases infectious diseases kidney disease pulmonary diseases musculoskeletal disorders reproductive and endocrine disorders dermatological diseases eye diseases the gut‒brain axis and microbiota-linked disorders The journal particularly welcomes: Cutting-edge studies in emerging areas of lipid research, including lipidomics, spatial lipidomics, and the integration of lipid data with other omics technologies such as genomics, transcriptomics, proteomics, and metabolomics, to identify novel lipid biomarkers and therapeutic targets. Research exploring the roles of lipids in immunometabolism, all areas of immunity, and the resolution of inflammation is especially encouraged. Research on lipid-based nanocarriers, including lipid nanopart

From the journal's Aims & Scope

Research area (LetPub): Biochemistry & Molecular Biology

Editor-in-chief A. M. AbdPublisher website

Editorial board by country: 4 in mainland China (about 7%); most named United States 10, United Kingdom 6, Italy 5, Mainland China 4, Brazil 4 (54 members with a country) Editorial board ↗Publisher website · 2026-09-29

CAS Journal Ranking

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEEmbaseCASCAB AbstractsPublisher website

Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

6.87LetPub · 2026-09-13

Impact factor (publisher) 2025

6.9Publisher website · 2026-09-29

5-year impact factor (publisher) 2025

6.4Publisher website · 2026-09-29

CiteScore 2026-06

7.3LetPub · 2026-09-13

SJR 2026-06

1.45LetPub · 2026-09-13

SNIP 2026-06

1.36LetPub · 2026-09-13

h-index

57LetPub · 2026-09-13

h-index

132OpenAlex · 2026-10-01

i10-index

2,976OpenAlex · 2026-10-01

2-year mean citedness

8.14OpenAlex · 2026-10-01

Self-citation rate

4.3%LetPub · 2026-09-13

Share of gold OA articles

100%LetPub · 2026-09-13

Volume

Articles per year

407LetPub · 2026-09-13

Downloads per year (publisher) 2025

4100000Publisher website · 2026-09-29

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

3–8 weeksLetPub · 2026-09-13

Average acceptance (community reports)

EasyLetPub · 2026-09-13

Submission to first decision

2 daysPublisher website · 2026-09-29

Submission to publication (journal-reported)

about 7 weeksDOAJ · 2026-10-25

Peer review

Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

• APC information ↗DOAJ
• Fee waivers ↗DOAJ
• Open access statement ↗DOAJ
• License & copyright ↗DOAJ

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Publisher

BioMed Central

Country or region

ENGLAND

Language

English

Frequency

Monthly

Founded

2002

ISSN

1476-511X

Official links

• Journal homepage ↗DOAJ
• Submission system ↗LetPub
• Author guidelines ↗LetPub
• Aims & Scope ↗LetPub
• Special issues ↗Publisher website
• APC information ↗DOAJ
• Fee waivers ↗DOAJ
• Open access statement ↗DOAJ
• License & copyright ↗DOAJ
• Peer review process ↗LetPub
• Editorial board ↗LetPub
• Plagiarism policy ↗DOAJ